First-generation antipsychotic (diphenylbutylpiperidine)
Pimozide
Brand names: Orap
Adult dose
Dose: Schizophrenia: 2–20mg OD. Tourette's: 1–10mg OD. Specialist initiation
Route: PO
Frequency: OD
Clinical pearls
- Tourette's syndrome, refractory schizophrenia — specialist
- ECG before and during therapy mandatory
Contraindications
- QT prolongation
- Concurrent CYP3A4/2D6 inhibitors
- Concurrent QT-prolonging drugs
- Hypokalaemia
Side effects
- QT prolongation
- Sudden cardiac death
- EPS
- Sedation
- Hyperprolactinaemia
- Anticholinergic effects
Interactions
- CYP3A4/2D6 inhibitors (clarithromycin, fluoxetine, paroxetine)
- QT-prolonging drugs
Monitoring
- ECG
- Electrolytes
- Weight
- Glucose
- Prolactin
Reference: BNF; SmPC; https://bnf.nice.org.uk/drugs/pimozide/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185 / BNF